Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PONTIAC follow-up trial of NT-proBNP-guided preventive cardioprotective therapy in type 2 diabetes
NL-OMON47526Phase 4Active, not recruiting
- Sponsor
- Medical University of Vienna
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of carvedilol in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Medical University of Vienna. Primary endpoints: Co-primary endpoint 1 and Co-primary endpoint 2. Started Mar 2018; status: active, not recruiting.
02
Drugs
carvedilol
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON47526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47526.